ALS Stem Cell Therapy Shows Safety and Efficacy in Early Clinical Trials

Biopharmaceutical company Neuralstem presented new and potentially promising results from its clinical investigations of NSI-566 — human spinal cord-derived neural stem cells for the treatment of conditions including amyotrophic lateral sclerosis (ALS) — at the recent Phacilitate Cell & Gene Therapy World conference in Washington, D.C. Karl Johe, the company’s chairman and chief scientific officer, reported that two clinical trials…

“Johns Hopkins neurologist, Jeffrey Rothstein, explains how sticky DNA causes ALS. He shows how one drug he identified works to de-stick the DNA so it no longer globs up proteins in the cell.” Learn more about ALS: https://bit.ly/ALSNewsToday…

People often worry about life and the things they don’t have. This documentary gives you an insight into the daily struggles of this horrific disease. ‘Enduring motor neurone disease’ itself shows Steve Evans and his loving family showing not only how it affects Steve, but also how the disease effects everyone around…

A report from the Boston University School of Public Health shows that Gulf War Illness is a result of exposure to pesticides and other toxins used in the Gulf War. The report also notes that in addition to Gulf War Illness, deployed Gulf War veterans suffer higher rates of stroke, brain cancer and…

In this video from 2009, researchers and doctors are working together at Johns Hopkins to explore the impact of stem technology on ALS. The Robert Packard Center for ALS Research at Johns Hopkins has helped uncover new genes for familial ALS, researched nerve repair, worked actively on genetic risk…

https://www.youtube.com/watch?v=LwypwQxlXhQ “In this short documentary by Frances Films, learn more about ALS and its journey in the last few years. Also learn more about the Ice Bucket Challenge phenomenon that raised over £7 million for the MNDA in the UK.” Learn more about ALS here: https://bit.ly/ALSNewsToday…

The U.S. Department of Defense announced that nine researchers are the winners of the 2015 ALS Research Program (ALSRP), which aims to improve treatment and find a cure for amyotrophic lateral sclerosis (ALS) by funding preclinical research into the disease. The winners were announced in a press release by the ALS…

https://www.youtube.com/watch?v=p5OoXkNIvHA Dr. Eva Feldman, a neurologist, researcher and director of the A. Alfred Taubman Biomedical Research Institute at the University of Michigan, is the principal investigator for a landmark clinical trial involving patients with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease. The FDA-approved trial, which is…

ALS, or Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease, makes all of your muscles stop, one by one. Watch this video to learn more about a secret project that ALS Foundation Netherlands launched to raise awareness for ALS. Learn more about ALS: https://bit.ly/ALSNewsToday…

Entrepreneur Kevin Gosnell announced the launch of ALS ONE – a partner organization of the ALS Association and ALS Finding a Cure that aims to bring world-leading experts in neurology and amyotrophic lateral sclerosis (ALS) care together to realize an ambitious goal: finding a new ALS treatment within four years.